
Latest scientific findings give hope for people with incurable retinal degeneration
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major reasons for visual impairment, round the globe, close to 200 million people are affected. Photoreceptors in the retina are responsible to capture the light coming from the environment through the eye. Diseased photoreceptors lose their sensitivity to light, which can lead to impaired vision or even complete blindness. Scientists of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) together with colleagues from the German Primate Center (DPZ) – Leibniz Institute for Primate Research in Göttingen have developed a completely new therapeutic approach based on gene therapy. They managed to activate degenerated photoreceptors using near-infrared light (Science).
The main cause of blindness in industrialized countries is the degeneration of photoreceptors, including age-related macular degeneration and retinitis pigmentosa. During the progression of degenerative photoreceptor diseases, light-sensitive and light-insensitive photoreceptor regions in the retina coexist. For example, macular degeneration patients lose vision in the central portion of their retina but retain peripheral eyesight.
Scientists have now succeeded in developing a new therapeutic approach to restore light sensitivity in degenerating retina without negatively affecting remaining vision. They were inspired by species found in nature, such as bats and snakes, that can localize near-infrared light emitted by the bodies of their preys. This is done by using heat-sensitive ion channels which are able to detect the heat of the near-infrared light. This enables the bats and snakes to superimpose thermal and visual images in the brain and thus react to their environment with greater precision. To equip retinal photoreceptors with near-infrared sensitivity, the researchers devised a three-component system. The first component contains engineered DNA that ensures that the gene coding for the heat-sensitive channel is only expressed in photoreceptors. The second component is a gold nanorod, a small particle, that efficiently absorbs near-infrared light. The third component is an antibody that ensures strong binding between the heat-sensitive channel expressed in photoreceptors and the gold nanorods that locally capture near-infrared light and locally release heat.
The researchers first tested their system in engineered mice with retinal degeneration, confirming that near-infrared light effectively excites photoreceptors and that this signal is transmitted to retinal ganglion cells, the latter representing the output of the retina towards higher visual centers in the brain. Next, they showed that stimulating the mouse eye with near-infrared light is also picked up by neurons in a brain area that is important for conscious vision, the primary visual cortex. They also designed a behavioral test in which untreated blind mice were not able to use near-infrared stimulation to learn a simple task whereas blind mice treated with the three-component system could perform the task related to near-infrared stimulus.
In collaboration with Arnold Szabo, a co-author of the paper and Assistant Professor at the Semmelweis University in Hungary, the researchers could test their new approach on human retinas that can be kept alive in culture medium for months, though blindness sets in a day or so after death by photoreceptors losing their ability to detect light. Experimental results showed that following treatment with the three-component gene therapy method, near-infrared light exposures reactivated the human retina’s visual circuitry.
“We believe that near-infrared stimulation is an important step towards providing useful vision to blind patients so that they can regain their ability to read or see faces”, says Daniel Hillier, head of the junior research group Visual Circuits and Repair at DPZ, and adds: “We want to give hope to blind people with these findings and will further intensify our research activities in this area here at DPZ within our main project, which focuses on the restoration of vision.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy to restore vision
- Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and ...
- Gene Therapy Improves Vision for Blind Patients
151; -- For the first time, researchers have shown that gene therapy can be used to improve vision for blind children and young adults. Two new studies document the treatment of six young people who ...
- Gene Therapy News
Gene Therapy Rapidly Improves Night Vision in Adults With Congenital Blindness ... on an experimental gene-therapy-like technique to restore the normal activity of the TCCF4 gene deficient in ...
- Seeing Clearly: The Latest Treatments For Diabetic Retinopathy
This piece is part of a series dedicated to the eye and improvements in restoring vision ... restore to normal function tissues and organs that have been damaged by disease, injured by trauma, or worn ...
- Explainer: What is gene therapy and how can it stop people going blind?
Gene therapy can change lives but it's extremely expensive.
Go deeper with Google Headlines on:
Gene therapy to restore vision
[google_news title=”” keyword=”infectious” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Incurable retinal degeneration
- Management of Choroidal Neovascularization in Myopic Macular Degeneration
Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...
- Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 854 (Advances in Experimental Medicine and Biology, 854) - Softcover
Contains the proceedings of the XVI International Symposium on Retinal Degeneration (RD2014), to be held July 13-18, 2014 at the Asilomar Conference Center in Pacific Grove, California. A majority of ...
- Neovascular Age-Related Macular Degeneration
Randomized, controlled clinical trials have demonstrated the value of laser photocoagulation and photodynamic therapy with verteporfin in selected patients with neovascular age-related macular ...
- China: World’s first quantum tech for vision health could help millions
Center for Eye and Vision Research researchers in Hong Kong, China is using quantum tech to detect and potentially treat age-related macular degeneration early.
- Macular degeneration articles from across Nature Portfolio
Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...
Go deeper with Google Headlines on:
Incurable retinal degeneration
[google_news title=”” keyword=”incurable retinal degeneration” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]